NCT05556031Not yet recruiting
Ambulatory Heart Failure Service Model Study
The Reduction of Decompensation and Unnecessary Cardiac Failure Emergency Admissions: Ambulatory Heart Failure Service Model
Source: ClinicalTrials.gov · Last updated 27 Sept 2022 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The aim of the study is to assess the efficacy of this new ambulatory service model in reducing heart failure hospitalization (HHF), improving clinical as well as functional outcomes of post-discharge patients with Heart Failure of reduced ejection fraction (HFrEF) and Heart failure with preserved Ejection Fraction (HFpEF).
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 500 (estimated)
- First submitted
- 15 Sept 2022
- Start date
- Oct 2022
- Primary completion date
- Oct 2027
- Lead sponsor
- Chinese University of Hong Kong
- Diseases
- Heart failure
- NCT number
- NCT05556031
What you commit to
- Study type: Observational
- Planned participants: 500
- From Oct 2022 to the primary completion date, Oct 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Cardiac mechanical support implantation like LVAD
- Life expectancy less than 1 year due to underlying significant comorbidities like metastatic cancer or end-stage COPD
- Haemodynamically severe uncorrected primary cardiac valvular disease planned for surgery or intervention during the course of the study.
Lab values
- End stage renal failure or eGFR \<15 mL/min/1.73m2 as measured during index hospitalization or requiring dialysis
Other
- Cardiogenic shock required inotropics
Who the study is looking for
- Dyspnoea (exertional or at rest) and 2 of the following signs:
- Congestion on chest X-ray
- Rales on chest auscultation
- Clinically relevant oedema (e.g. ≥1+ on a 0 to 3+ scale)
- Elevated jugular venous pressure
- NT-proBNP ≥300 pg/mL (Patients with AF: NT-proBNP ≥900 pg/mL)
- Heart failure hospitalization that requires the treatment of a minimum single dose of 40 mg of i.v. furosemide (or equivalent i.v loop diuretics)
- Ambulatory patients
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The Chinese University of Hong Kong Coordinator of this site? Confirm its status | Shatin | Hong Kong SAR China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.